Tri-cyclic pyrazolopyridine kinase inhibitors

Details for Australian Patent Application No. 2009274027 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Jimenez, Juan-Miguel; Studley, John; Knegtel, Ronald; Settimo, Luca; Davis, Chris; Fraysse, Damien; Collier, Philip; Brenchley, Guy; Boyall, Dean; Miller, Andrew; Twin, Heather; Young, Stephen

Agent Baldwins

Pub. Number AU-A-2009274027

PCT Pub. Number WO2010/011772

Priority 61/140,100 23.12.08 US; 61/163,152 25.03.09 US; 61/116,032 19.11.08 US; 61/082,919 23.07.08 US

Filing date 22 July 2009

Wipo publication date 28 January 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/011772 Priority application(s): WO2010/011772

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274031-Method of characterizing sequences from genetic material samples

2009274023-Tri-cyclic pyrazolopyridine kinase inhibitors